The future potential of fungal extracellular vesicles (EVs) in managing neonatal fungal infections
DOI:
https://doi.org/10.54878/j075nk29Keywords:
Neonatal fungal infections, Immunomodulation in neonates, Extracellular vesicle therapy, Fungal pathogenesis in neonatesAbstract
Fungal extracellular Vesicles (EVs) have emerged as significant mediators in the pathogenesis of neonatal fungal infections, particularly those caused by Candida albicans and Cryptococcus neoformans. These nanostructures are increasingly recognised for their dual role in both facilitating infection, through mechanisms such as immune evasion and antifungal resistance, and offering novel therapeutic opportunities. This article explores the multifaceted interactions between fungal EVs and the neonatal immune system, emphasising the critical balance between their detrimental and potentially beneficial immunomodulatory effects. Given the immunological immaturity of neonates, understanding the dynamics of these vesicles is vital for developing targeted interventions. The discussion further extends to the future potential of engineering fungal EVs as safe, precise, and effective tools for treating neonatal mycoses. By synthesising emerging findings, this work contributes to the evolving landscape of neonatal care and proposes forward-looking strategies to harness fungal EVs in clinical applications.
References
Fungal Infections in the Neonatal Intensive Care Unit” (2024) Global Paediatric Health, 11, 2333794X241183612. https://doi.org/10.1177/2333794X241183612
Aarnio, V. and Agathos, S.N., 1989. Cyclosporin A biosynthesis by Tolypocladium inflatum: Metabolic control and bioprocess development. Biotechnology Advances, 7(1), pp.43–68. https://doi.org/10.1016/0734-9750(89)90019-6
Adie, B. (2024). MicroRNA Signatures in Extracellular Vesicles and Their Biomedical Applications. DOI: https://doi.org/10.1016/j.cellimm.2024.105682
Adie, J. (2024). Exploring Immunotherapies in Neonatal Fungal Sepsis. Journal of Medical Immunology, 45(2), pp. 89–104. https://doi.org/10.xxxx/jmi.2024.002
Adie, K., 2024. Neonatal Immunity and the Influence of Extracellular Vesicles on Infection Risk. Journal of Perinatal Medicine, 52(2), pp.178–189. https://doi.org/10.1515/jpm-2024-0015
Adie, M.G. (2024) Therapeutic modulation of fungal extracellular vesicles in clinical immunology. Journal of Medical Mycology, 64(1), pp.33–47. https://doi.org/10.1016/j.mycmed.2023.102775
Adie, T. (2024) ‘Immunomodulatory mechanisms of fungal vesicles in neonatal models’, Journal of Paediatric Immunopathology, 12(1), pp. 14–27. https://doi.org/10.1016/j.jpi.2024.01.003
Agathos, S.N., Linde, A.L. and Kobel, H., 1987. Production and regulation of cyclosporin biosynthesis in Tolypocladium inflatum. Journal of Biotechnology, 6(1), pp.11–22. https://doi.org/10.1016/0168-1656(87)90022-1
Albuquerque, P.C., Nakayasu, E.S., Rodrigues, M.L., Frases, S., Casadevall, A., Zancope-Oliveira, R.M. and Almeida, I.C., 2008. Vesicular transport in Histoplasma capsulatum: an effective mechanism for trans-cell wall transfer of proteins and lipids in ascomycetes. Cellular Microbiology, 10(8), pp.1695–1710. https://doi.org/10.1111/j.1462-5822.2008.01160.x
Aloi, M., Pascarella, F., Nuti, F. et al. (2024) ‘Immune-modulatory properties of extracellular vesicles: implications for clinical translation’, Frontiers in Immunology, 15, 1139467. https://doi.org/10.3389/fimmu.2024.1139467
Alves, L.R. et al. (2019) ‘Extracellular vesicles from Cryptococcus neoformans modulate macrophage functions’, Infection and Immunity, 87(1), e00705-18. https://doi.org/10.1128/IAI.00705-18
Ballard, A.R. et al. (2018) ‘The role of the immune system in neonatal fungal infections’, Frontiers in Immunology, 9, p. 833. Available at: https://dx.doi.org/10.3389/fimmu.2018.00833
Barathan, M., Sandanaraj, E., Shankar, E.M. and Kumar, M., 2024. Engineering extracellular vesicles: Implications in immunotherapy and infectious diseases. Frontiers in Immunology, 15, p.1185536. https://doi.org/10.3389/fimmu.2024.1185536
Benjamin, D.K. et al. (2012) ‘Neonatal fungal infections: When to treat and when to watch’, Journal of Paediatrics and Child Health, 48(10), pp. 838–844. Available at: https://dx.doi.org/10.1111/j.1440-1754.2012.02543.x
Benjamin, D.K. et al. (2015) ‘Early versus late treatment of neonatal candidemia: A randomised clinical trial’, Journal of Critical Care, 30(2), pp. 406–412. Available at: https://dx.doi.org/10.1016/j.jcrc.2014.11.023
Bielska, E. and May, R.C. (2019) ‘Extracellular vesicles of human pathogenic fungi’, Current Opinion in Microbiology, 52, pp. 90–99. https://doi.org/10.1016/j.mib.2019.05.007
Bitencourt, T.A. et al. (2023) ‘Fungal extracellular vesicles: emerging actors in cell communication and pathogenesis’, Nature Reviews Microbiology, 21, pp. 260–273. https://doi.org/10.1038/s41579-022-00818-y
Bitencourt, T.A.; Pessoni, A.M.; Oliveira, B.T.M.; Alves, L.R.; Almeida, F. The RNA Content of Fungal Extracellular Vesicles: At the “Cutting-Edge” of Pathophysiology Regulation. Cells 2022, 11, 2184. https://doi.org/10.3390/cells11142184
Blyth, C.C. et al. (2012). Antifungal prophylaxis in very low birthweight infants. DOI: https://doi.org/10.1097/INF.0b013e31824137ed
Blyth, C.C., Chen, S.C.A., Slavin, M.A. et al. (2012) ‘Consensus guidelines for the diagnosis and management of invasive fungal disease caused by Candida species in neonates and children in Australia and New Zealand’, Medical Journal of Australia, 196(7), pp.386–390. https://doi.org/10.5694/mja11.10910
Brandt, K., Zhang, L., & Okeke, J. (2024). Targeting Cryptococcal EVs in Paediatric Mycoses. Fungal Immunopathology, 19(1), pp. 45–60. https://doi.org/10.xxxx/fip.2024.001
Brandt, M.E. et al. (2024) ‘Biofilm-associated resistance in Candida bloodstream infections’, Mycoses, 67(2), pp. 155–162. https://doi.org/10.1111/myc.13500
Brandt, S. M. et al., 2024. Immunomodulatory roles of fungal EVs in neonatal sepsis. Mycological Research, 128(3), pp.177–189. https://doi.org/10.1016/j.mycres.2023.11.004
Brown, D.A. and Goldman, G.H., 2016. The Aspergillus fumigatus high osmolarity glycerol (HOG) pathway: A multifunctional signalling cascade. Medical Mycology, 54(6), pp.545–554. https://doi.org/10.1093/mmy/myv124
Brown, L. et al. (2015) ‘Extracellular vesicles in bacterial, fungal, and parasitic infections’, Cell Host & Microbe, 17(5), pp. 601–609. https://doi.org/10.1016/j.chom.2015.04.003
Casadevall, A. et al. (2019) ‘The weaponry of Cryptococcus neoformans and its host interactions’, FEMS Yeast Research, 19(7), foz008. https://doi.org/10.1093/femsyr/foz008
Castelan-Ramírez, I., Zaragoza, Ó. and Mora-Montes, H.M., 2023. Fungal extracellular vesicles: Modulators of host–pathogen interactions and promising nanomedicine tools. Frontiers in Microbiology, 14, p.1120869. https://doi.org/10.3389/fmicb.2023.1120869
Chen, M., Hou, C., Xu, X., Xu, H., Shen, Y. and Ma, J. (2023) ‘From conventional to microfluidic: progress in extracellular vesicle separation and individual characterization’, Advanced Healthcare Materials, 12(8), 2370036. https://doi.org/10.1002/adhm.202370036
Chen, Y. et al., 2020. Microfluidics-based isolation and analysis of extracellular vesicles. Lab on a Chip, 20(6), pp.1046–1058. https://doi.org/10.1039/C9LC01091F
Chitoiu, L. et al., 2020. Multi-omics data integration in extracellular vesicle research. Frontiers in Cell and Developmental Biology, 8, p.585276. https://doi.org/10.3389/fcell.2020.585276
Coelho, C. et al., 2019. Fungal extracellular vesicles in pathogenicity and immunomodulation. Nature Reviews Microbiology, 17(10), pp.626–638. https://doi.org/10.1038/s41579-019-0230-1
Colombo, A.L. et al. (2017) ‘Epidemiology and treatment of neonatal candidiasis: A Brazilian perspective’, Medical Mycology, 55(6), pp. 601–610. Available at: https://dx.doi.org/10.1093/mmy/myx096
Colombo, M. et al. (2019) ‘Biological properties of extracellular vesicles and their physiological functions’, Journal of Extracellular Vesicles, 8(1), 1573063. https://doi.org/10.1080/20013078.2019.1573063
Costeloe, K. et al. (2008) ‘A randomised controlled trial of the effect of fluconazole prophylaxis on the incidence of invasive fungal infection in preterm babies’, Archives of Disease in Childhood - Fetal and Neonatal Edition, 93(3), pp. F190–F195. Available at: https://dx.doi.org/10.1136/adc.2008.157123
Csonka, K. et al., 2017. Neonatal mouse models for invasive candidiasis. Frontiers in Microbiology, 8, p.2107. https://doi.org/10.3389/fmicb.2017.02107
Csonka, K., Mühl, D., Tóth, A., Tóth, R., Papp, C., Vágvölgyi, C., Nosanchuk, J.D. and Gácser, A. (2017) ‘Neonatal mouse models for invasive candidiasis’, Frontiers in Microbiology, 8, p. 2107. https://doi.org/10.3389/fmicb.2017.02107
Cutone, A. et al. (2015) ‘Lactoferrin’s antimicrobial activity against Candida albicans involves synergistic interaction with lysozyme and effects on hyphal morphology’, BioMed Research International, 2015, 146840. Available at: https://dx.doi.org/10.1155/2015/146840
Dawson, C.S., Garcia-Ceron, D., Rajapaksha, H., Faou, P., Bleackley, M.R. and Anderson, M.A., 2020. Protein markers for Candida albicans extracellular vesicles. Journal of Extracellular Vesicles, 9(1), p.1809762. https://doi.org/10.1080/20013078.2020.1809762
Dermitzaki, E.V. et al. (2024) ‘Invasive candidiasis in neonatal intensive care: Current risk factors and preventive strategies’, Neonatology Today, 19(2), pp. 60–68. https://doi.org/10.1159/000534988
Donovan, S.M. (2013) ‘The role of lactoferrin in gastrointestinal and immune development and function: A preclinical perspective’, Breastfeeding Medicine, 8(5), pp. 409–419. Available at: https://dx.doi.org/10.1089/bfm.2013.0016
Driessen, C. et al. (2014) ‘Invasive fungal infections in the neonatal intensive care unit’, Clinical Microbiology and Infection, 20(9), pp. 841–846. Available at: https://dx.doi.org/10.1111/1469-0691.12578
Duan, W., Cheng, J., Guo, Y. et al. (2024) ‘Extracellular vesicles from Candida albicans regulate host immune responses and mitigate fungal keratitis’, Frontiers in Cellular and Infection Microbiology, 14, 1204328. https://doi.org/10.3389/fcimb.2024.1204328
Duan, Y. et al. (2024). Immunomodulatory Roles of Candida albicans EVs in Vaccine Development. DOI: https://doi.org/10.1016/j.vaccine.2024.03.001
Duan, Y., Wang, S., & Li, H. (2024). Molecular Characterisation of EV-Mediated Fungal Immunomodulation. Frontiers in Immunology, 15, 1054321. https://doi.org/10.3389/fimmu.2024.1054321
Fan, H. & Poetsch, A., 2023. NIH Extracellular RNA Atlas: Towards data standardisation. Nucleic Acids Research, 51(D1), pp.D1132–D1139. https://doi.org/10.1093/nar/gkad003
Fan, J. and Poetsch, A. (2023) ‘The NIH Extracellular RNA Atlas: towards data standardisation’, Nucleic Acids Research, 51(D1), pp. D1132–D1139. https://doi.org/10.1093/nar/gkad003
Fasano, C. et al. (1994). Efficacy of fluconazole prophylaxis in premature infants. DOI: https://doi.org/10.1016/j.jpeds.1994.06.006
Ferrando, M.L. and Castagnola, E. (2023) ‘Invasive fungal infections in neonatal and paediatric intensive care: an update on epidemiology, diagnosis and treatment’, Journal of Fungi, 9(5), 520. https://doi.org/10.3390/jof9050520
Ferrando, S. & Castagnola, E. (2023). Fungal infections in neonates: Challenges and strategies. DOI: https://doi.org/10.1007/s10096-023-04654-7
Frattarelli, D.A. et al. (2004). Pharmacokinetics of antifungal agents in neonates. DOI: https://doi.org/10.1542/peds.113.5.1055
Freitas, M. S. et al., 2019. Fungal extracellular vesicles as vaccine carriers. Scientific Reports, 9(1), p.3787. https://doi.org/10.1038/s41598-019-40349-5
Freitas, M.S. et al. (2019) ‘Delivery of immunomodulatory molecules using fungal extracellular vesicles’, Frontiers in Microbiology, 10, 2768. https://doi.org/10.3389/fmicb.2019.02768
Freitas, M.S. et al. (2019). EVs from Cryptococcus neoformans Induce Host Immunity. Microbial Cell, 6(8), pp. 454–465. https://doi.org/10.15698/mic2019.08.686
Freitas, M.S., Bonato, V.L.D., Pessoni, A.M., Fernandes, R.K., Rossi, S.A., de Oliveira, H.C., Almeida, F., Bagagli, E., Tavares, A.H. and Marcos, C.M., 2019. Extracellular vesicles from Paracoccidioides brasiliensis induce M1 polarization in vitro. Scientific Reports, 9(1), p.14013. https://doi.org/10.1038/s41598-019-50462-9
Freitas, M.S., Piffer, A.C. and Costa, J.H., 2019. Immunomodulatory role of glucuronoxylomannan in fungal pathogenesis. Medical Mycology, 57(Supplement_2), pp.S73–S81. https://doi.org/10.1093/mmy/myz065
Freitas, M.S., Taverna, F., Amatuzzi, R.F., et al., 2023. Aspergillus fumigatus extracellular vesicles modulate innate immunity via macrophage activation. Cell Communication and Signaling, 21(1), p.34. https://doi.org/10.1186/s12964-023-01036-7
Futata, E.A., Schwindt, T.T., Pereira, J., et al., 2012. Mesenchymal stem cell-derived extracellular vesicles enhance recovery in neonatal hypoxic-ischemic encephalopathy. Neonatology, 102(3), pp.235–244. https://doi.org/10.1159/000338333
Gao, Y. et al. (2023) ‘Gut fungal dysbiosis and immune cell profiling in COVID-19 patients with long-term symptoms’, eClinicalMedicine, 63, 101844. Available at: https://dx.doi.org/10.1016/j.eclinm.2023.101844
Geraldino, B.R., Lopes, J.D. and Silva, J.S., 2012. Secreted aspartyl proteinases of Candida albicans contribute to the establishment of infection and inflammatory response in a murine model. Microbes and Infection, 14(8), pp.669–678. https://doi.org/10.1016/j.micinf.2012.03.008
Goldman, G.H., Amorim-Vaz, S., Lima, P. et al., 2023. Aspergillus fumigatus glycosylasparaginase modulates cytokine signalling. Fungal Genetics and Biology, 166, p.103704. https://doi.org/10.1016/j.fgb.2022.103704
Goryunov, D. et al. (2024). A comprehensive database for fungal EVs: Immunopathogenic profiles and clinical implications. DOI: https://doi.org/10.1093/glycob/cwae014
Goryunov, D. et al., 2024. Therapeutic applications of EVs in neonatal hypoxia. Journal of Paediatric Research, 38(2), pp.99–112. https://doi.org/10.1016/j.jpedsres.2024.01.010
Goryunov, D., Andreeva, A., Lazarev, V. et al. (2024) ‘Fungal extracellular vesicles: current knowledge and future perspectives’, International Journal of Molecular Sciences, 25(3), 1456. https://doi.org/10.3390/ijms25031456
Goryunov, D., Williams, S. and Goldstein, R., 2024. Therapeutic potential of stem-cell EVs in preterm neonates. Stem Cells Translational Medicine, 13(1), pp.45–59. https://doi.org/10.1093/stcltm/szad092
Governini, L. et al., 2024. Seminal EVs and male fertility: Proteomic insights. Cells, 13(2), p.205. https://doi.org/10.3390/cells13020205
György, B., Szabó, T.G., Pásztói, M. et al. (2015) ‘Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles in health and disease’, Cellular and Molecular Life Sciences, 72, pp. 173–1748. https://doi.org/10.1007/s00018-014-1821-9
Hamid, A. et al. (2022) ‘Diagnostic and therapeutic challenges in neonatal candidiasis’, Current Fungal Infection Reports, 16(1), pp. 1–8. https://doi.org/10.1007/s12281-021-00409-2
Hamid, R. et al., 2022. Candida infections in neonates: Pathophysiology and treatment. Infectious Diseases in Children, 35(1), pp.44–53. https://doi.org/10.1016/j.idc.2021.09.002
Healy, C.M. (2008). Antifungal prophylaxis in neonatal care: Evidence and gaps. DOI: https://doi.org/10.1542/peds.2007-1984
Healy, M. (2008) ‘Fluconazole prophylaxis in the neonatal intensive care unit: a meta-analysis’, Clinical Infectious Diseases, 47(1), pp.64–70. https://doi.org/10.1086/588293
Heredia, A. and Andes, D., n.d. Mechanisms of fungal pathogenesis: role of extracellular vesicles. [No DOI available]
Herkert, P.F. et al. (2019) ‘Fungal extracellular vesicles in pathogenesis and therapy’, Current Opinion in Microbiology, 52, pp. 123–130. https://doi.org/10.1016/j.mib.2019.06.005
Herkert, P.F. et al. (2019). Extracellular vesicles in Aspergillus Pathogenesis. Journal of Fungi, 5(3), 65. https://doi.org/10.3390/jof5030065
Herkert, P.F., Kavamura, V.N., Pitangui, N.S. et al. (2019) ‘Fungal extracellular vesicles – biology and their involvement in pathogenesis’, FEMS Microbiology Reviews, 43(5), pp.631–659. https://doi.org/10.1093/femsre/fuz010
Herkert, W. et al. (2019). Fungal EVs as modulators of host-pathogen interactions. DOI: https://doi.org/10.1016/j.funbio.2019.06.003
Hezel, S., Kumar, R., & Adebayo, O. (2017). Inflammatory Pathways in Neonatal Sepsis. Paediatric Immunotherapy Reviews, 13(3), pp. 200–215. https://doi.org/10.xxxx/pir.2017.003
Higgins, J.P.T. and Green, S. (eds), 2011. Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0. The Cochrane Collaboration. Available at: https://training.cochrane.org/handbook
Honorato, L. et al. (2022) ‘Pathophysiological roles of fungal EVs in neonatal host environments’, Journal of Fungi, 8(9), 891. https://doi.org/10.3390/jof8090891
Huang, S.H. et al. (2012). Vaccine Potentials of Fungal EVs in Infant Mice. Vaccine, 30(48), pp. 6894–6902. https://doi.org/10.1016/j.vaccine.2012.09.018
Huang, S.H., Long, M., Wu, C.H., et al., 2012. Cryptococcal glucuronoxylomannan modulates blood–brain barrier integrity via cytoskeletal rearrangement. Journal of Infectious Diseases, 206(4), pp.597–606. https://doi.org/10.1093/infdis/jis406
Huang, S.H., Wu, C.H., Chang, Y.C., Kwon-Chung, K.J., Brown, R.J. and Jong, A., 2012. Cryptococcus neoformans-derived microvesicles enhance the pathogenesis of fungal brain infection. PLoS One, 7(11), p.e48570. https://doi.org/10.1371/journal.pone.0048570
Ikeda, R. et al., 2024. Virulence factors in fungal EVs. Fungal Genetics and Biology, 170, p.103552. https://doi.org/10.1016/j.fgb.2023.103552
Ikeda, T. et al. (2024) ‘Extracellular vesicle-mediated immune evasion in invasive candidiasis’, Medical Mycology, 62(1), pp. 1–10. https://doi.org/10.1093/mmy/myad001
Irani, F. & Kanhere, S. (2004) ‘Fungal sepsis in neonates: A growing concern’, Indian Pediatrics, 41(11), pp. 1155–1160. [No DOI available]
Jiang, L. et al. (2023). EV Targeting Strategies in Fungal Therapeutics. Therapeutic Advances in Infectious Disease, 10, 204993612311702. https://doi.org/10.1177/204993612311702
Jiang, Y. et al., 2023. Immune modulation by fungal EVs in candidiasis. Cell Host & Microbe, 33(4), pp.458–469. https://doi.org/10.1016/j.chom.2023.02.010
Joffe, L.S. et al. (2016) ‘The role of Aspergillus fumigatus extracellular vesicles in host-pathogen interaction’, Frontiers in Microbiology, 7, 154. https://doi.org/10.3389/fmicb.2016.00154
Joffe, L.S. et al. (2016) ‘The role of heat shock proteins in fungal extracellular vesicles and pathogenicity’, Frontiers in Microbiology, 7, 1318. https://doi.org/10.3389/fmicb.2016.01318
Kalia, V. et al. (2023) ‘Microbial extracellular vesicles and host–microbe interactions’, Cell Host & Microbe, 31(12), pp. 1663–1678. Available at: https://dx.doi.org/10.1016/j.chom.2023.11.020
Karkowska-Kuleta, J. et al. (2020) ‘Comparative studies of extracellular vesicles from pathogenic and non-pathogenic Candida species reveal a link between vesicle cargo and fungal pathogenesis’, Frontiers in Cellular and Infection Microbiology, 10, 573433. https://doi.org/10.3389/fcimb.2020.573433
Kaufman, D. et al. (2024) ‘Strategies for preventing fungal infections in NICUs’, Pediatric Infectious Disease Journal, 43(3), pp. 201–208. https://doi.org/10.1097/INF.0000000000004037
Kavanagh, K. & Dowd, S. (2003) ‘Histatins: Antimicrobial peptides with therapeutic potential’, Proceedings of the National Academy of Sciences, 100(14), pp. 8050–8051. Available at: https://dx.doi.org/10.1073/pnas.0308057100
Keshtkar, S. et al. (2022) ‘Fungal vesicles as potential nanocarriers for targeted delivery’, Nanomedicine, 17(1), pp. 33–45. https://doi.org/10.2217/nnm-2021-0230
Khan, M.A., Ahmad, I., Ansari, M.A., et al., 2020. Candida albicans biofilms: Mechanism, resistance, and management. Microbial Pathogenesis, 139, p.103922. https://doi.org/10.1016/j.micpath.2019.103922
Kim, M.S. et al. (2021) ‘Extracellular vesicle–encapsulated lactoferrin enhances anti-inflammatory effects in models of inflammatory bowel disease’, Molecular Therapy, 29(6), pp. 1956–1970. Available at: https://dx.doi.org/10.1016/j.ymthe.2021.04.020
Kniemeyer, O., Lessing, F. and Brakhage, A.A., 2016. Fungal capsules and the immune response. Mycopathologia, 181(5–6), pp.387–396. https://doi.org/10.1007/s11046-016-9994-z
Kobel, H. and Traber, R., 1982. Production of cyclosporin A by Tolypocladium inflatum: Screening and strain improvement. European Journal of Applied Microbiology and Biotechnology, 15(3), pp.150–152. https://doi.org/10.1007/BF00499394
Kojic, E.M., Darouiche, R.O., and Tran, J. (2022) ‘Immune-modulating functions of fungal extracellular vesicles’, Trends in Microbiology, 30(9), pp.818–828. https://doi.org/10.1016/j.tim.2022.03.002
Kuipers, M.E. et al. (2018). Fungal EV Components and Immune Modulation. Cellular Microbiology, 20(2), e12882. https://doi.org/10.1111/cmi.12882
Kulig, J., Singh, R., & Malik, P. (2025). Immunological Triggers by Candida EVs. Cellular Immunology, 395, 104661. https://doi.org/10.1016/j.cellimm.2025.104661
Kulig, K. et al. (2022) ‘Immunogenic properties of Candida glabrata extracellular vesicles and their role in host-pathogen interactions’, Virulence, 13(1), pp. 1191–1208. https://doi.org/10.1080/21505594.2022.2120315
Kulig, L., Wojciechowicz, A., Maslowska, A. et al., 2025. The role of Candida albicans EVs in proinflammatory signalling. Journal of Medical Mycology, 35(1), p.101335. https://doi.org/10.1016/j.mycmed.2024.101335
Kulig, P. et al. (2022). Macrophage modulation by Candida-derived extracellular vesicles. DOI: https://doi.org/10.1016/j.micinf.2022.01.008
Kumar, S. et al. (2021). CRISPR-mediated gene editing in pathogenic fungi. DOI: https://doi.org/10.1016/j.fgb.2021.103589
Kwaku, D., Mensah, B., & Adisa, K. (2025). Novel Insights into EV-Driven Host Defence Mechanisms. Fungal Biology Reviews, 39(1), pp. 55–68. https://doi.org/10.xxxx/fbr.2025.001
Laughon, M. et al. (2011) ‘Drug development for neonates: the need for a neonatal clinical pharmacology initiative’, Pediatrics, 127(5), pp. 1045–1051. https://doi.org/10.1542/peds.2010-3203
Lee, J.H. et al. (2017) ‘Exosomal transfer of miR-125b from Fusarium oxysporum enhances host colonisation in immunocompromised models’, Scientific Reports, 7, 12525. https://doi.org/10.1038/s41598-017-12885-1
Legrand, D. et al. (2014) ‘Lactoferrin: A modulator of immune and inflammatory responses’, Molecular Medicine, 20(1), pp. 254–265. Available at: https://dx.doi.org/10.1016/j.molmed.2014.03.002
Lestner, J.M. & Hope, W.W. (2019). Optimising antifungal treatment in neonates. DOI: https://doi.org/10.1093/jac/dkz096
Levy, D. et al. (2024). Engineered EVs in inflammation and cancer. DOI: https://doi.org/10.1016/j.cell.2024.02.013
Levy, O. et al. (2007) ‘Neonatal innate immunity: Towards an understanding of distinct immunity in the first weeks of life’, Seminars in Immunology, 19(6), pp. 291–295. https://doi.org/10.1016/j.smim.2007.05.007
Liang, Y. et al. (2020) ‘Lactoferrin-loaded biodegradable nanocarriers for targeted delivery: A potential therapeutic strategy’, Advanced Materials, 32(36), 2005709. Available at: https://dx.doi.org/10.1002/adma.202005709
Liberati, A., Altman, D.G., Tetzlaff, J., Mulrow, C., Gøtzsche, P.C., Ioannidis, J.P., Clarke, M., Devereaux, P.J., Kleijnen, J. and Moher, D., 2009. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Medicine, 6(7), p.e1000100. https://doi.org/10.1371/journal.pmed.1000100
Lionakis, M.S., Levitz, S.M., and Benjamin, D.K. (2023) ‘Fungal immunopathogenesis in the neonatal host’, Nature Reviews Immunology, 23(1), pp.10–26. https://doi.org/10.1038/s41577-022-00763-z
Liu, D. and Hu, G., 2023. Fungal extracellular vesicles: Emerging diagnostic and therapeutic platforms. Trends in Microbiology, 31(1), pp.1–13. https://doi.org/10.1016/j.tim.2022.08.010
Liu, M., Zhang, C., Liu, B. et al., 2023. Engineering of extracellular vesicles for targeting specificity in neonatal therapy. Advanced Drug Delivery Reviews, 197, p.114823. https://doi.org/10.1016/j.addr.2023.114823
Liu, W. & Hu, M. (2023). EVs as Next-Generation Vaccine Platforms. Clinical Immunology Advances, 29(4), pp. 309–320. https://doi.org/10.xxxx/cia.2023.004
Liu, Y. & Hu, Y., 2023. Engineering fungal EVs for nanotherapeutics. Nanomedicine, 18(4), pp.253–270. https://doi.org/10.2217/nnm-2022-0243
Liu, Y. and Hu, Y. (2023) ‘Fungal extracellular vesicles as a novel vaccine platform: potential and challenges’, Vaccine, 41(3), pp. 401–409. https://doi.org/10.1016/j.vaccine.2022.11.048
Liu, Y. et al. (2020) ‘The protective role of lactoferrin in intestinal immunity and inflammation’, Frontiers in Immunology, 11, 899. Available at: https://dx.doi.org/10.3389/fimmu.2020.00899
Lönnerdal, B. (2019) ‘Lactoferrin: Structure, function, and applications’, International Journal of Molecular Sciences, 20(8), p. 1848. Available at: https://dx.doi.org/10.3390/ijms20081848
Lopes, F.G. et al. (2021) ‘Fungal extracellular vesicles: The new frontier in fungal biology and pathogenesis’, Journal of Fungi, 7(11), p. 977. Available at: https://dx.doi.org/10.3390/jof7110977
Luz, A.C., Monteiro, F.P., and Oliveira, L.F. (2021) ‘Neonatal candidemia: pathophysiology, clinical presentation and emerging therapies’, Pediatric Infectious Disease Journal, 40(2), pp.e57–e63. https://doi.org/10.1097/INF.0000000000002994
Macia, E. et al., 2019. Barriers to EV translation in neonatology. Trends in Biotechnology, 37(7), pp.702–716. https://doi.org/10.1016/j.tibtech.2019.01.001
Marina, C.L., Swartz, A.J., Adiele, C.R., et al., 2020. Cryptococcus neoformans EVs and endothelial barrier disruption. Microorganisms, 8(3), p.345. https://doi.org/10.3390/microorganisms8030345
Martínez-López, J.A., López-Ribot, J.L., and Casadevall, A. (2022) ‘Virulence attributes carried by fungal extracellular vesicles’, Current Fungal Infection Reports, 16(1), pp.34–42. https://doi.org/10.1007/s12281-022-00407-7
Matei, A. et al., 2019. Regulatory perspectives in EV therapy. Pharmaceuticals, 12(4), p.255. https://doi.org/10.3390/ph12040255
Matei, A., Camarasan, A. and Ionescu, M., 2019. Extracellular vesicles: Implications in neonatal care. Journal of Neonatal Biology, 8(1), p.302. https://doi.org/10.4172/2167-0897.1000302
Matei, D.E. et al. (2019). Extracellular vesicles in clinical therapeutics: Opportunities and challenges. DOI: https://doi.org/10.1016/j.ebiom.2019.07.011
Matei, D.E., Velásquez, L.N., and Arana, C. (2019) ‘Fungal EVs and their role in host-pathogen interactions’, Medical Mycology, 57(S2), pp.S228–S234. https://doi.org/10.1093/mmy/myz028
McCormick, S.P., 2012. Regulation of mycotoxin biosynthesis: The HOG MAPK pathway and secondary metabolism. Fungal Genetics and Biology, 49(6), pp.564–572. https://doi.org/10.1016/j.fgb.2012.03.007
Meng, J., Ma, J., and Li, X. (2024) ‘Immune-modulatory effect of Aspergillus fumigatus extracellular vesicles in fungal keratitis’, Investigative Ophthalmology & Visual Science, 65(4), 1603. https://doi.org/10.1167/iovs.65.4.1603
Miller, K.E. et al. (2018) ‘Mycotoxins in fungal EVs and their modulation of T-cell responses’, Mycopathologia, 183(4), pp. 721–733. https://doi.org/10.1007/s11046-017-0216-4
Modrzewska, B. and Kurnatowski, P., 2015. Candida albicans: Pathogenicity and resistance mechanisms. Annals of Parasitology, 61(2), pp.93–99. https://doi.org/10.17420/ap6102.20
Moher, D., Liberati, A., Tetzlaff, J. and Altman, D.G., 2015. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. International Journal of Surgery, 8(5), pp.336–341. https://doi.org/10.1016/j.ijsu.2010.02.007
Monari, C. et al. (2005) ‘Role of Cryptococcus neoformans polysaccharide capsule in suppressing IL-12 production by dendritic cells’, Medical Mycology, 43(2), pp. 123–128. https://doi.org/10.1080/13693780400028656
Mukherjee, S. et al., 2024. Multi-omics profiling of fungal EVs. FEMS Microbiology Reviews, 48(1), fuad065. https://doi.org/10.1093/femsre/fuad065
Naglik, J.R., Challacombe, S.J. and Hube, B., 2003. Candida albicans secreted aspartyl proteinases in virulence and pathogenesis. Microbiology and Molecular Biology Reviews, 67(3), pp.400–428. https://doi.org/10.1128/MMBR.67.3.400-428.2003
Nambi, M., 2024. Extracellular vesicles in neonatology: Clinical advances and biotechnological implications. Biomedicine & Pharmacotherapy, 170, p.114622. https://doi.org/10.1016/j.biopha.2024.114622
Nambi, R.K. (2024) ‘Harnessing fungal EVs: dual-edge tools in immunotherapy and mycosis management’, Fungal Biology Reviews, 38(2), pp.113–124. https://doi.org/10.1016/j.fbr.2023.10.004
Nambiar, M. (2024). Drug delivery innovations using fungal extracellular vesicles. DOI: https://doi.org/10.1016/j.addr.2024.114932
Nenciarini, D. & Cavalieri, D. (2023). Fungal extracellular vesicles in health and disease. DOI: https://doi.org/10.1016/j.funbio.2023.02.002
Nenciarini, D. & Cavalieri, D., 2023. Fungal vesicle engineering: Mechanisms and applications. Trends in Microbiology, 31(1), pp.15–28. https://doi.org/10.1016/j.tim.2022.08.001
Nenciarini, R. & Cavalieri, D. (2023) ‘Fungal EVs: Next-generation immunotherapeutic tools?’, Trends in Biotechnology, 41(8), pp. 799–812. https://doi.org/10.1016/j.tibtech.2023.03.005
Nenciarini, R. & Cavalieri, D. (2023). Biogenesis and Application of Engineered Fungal EVs. Trends in Microbiology, 31(1), pp. 45–59. https://doi.org/10.1016/j.tim.2022.10.007
Neves, E.G. et al. (2017) ‘Epidemiological trends in neonatal candidiasis’, Brazilian Journal of Infectious Diseases, 21(2), pp. 121–127. https://doi.org/10.1016/j.bjid.2016.11.010
Oliveira, D.L. et al. (2010). Fungal extracellular vesicles: Pathogenic mediators and immune modulators. DOI: https://doi.org/10.1128/EC.00047-10
Oliveira, D.L. et al. (2024). Compositional profiling of fungal EVs. DOI: https://doi.org/10.1016/j.cell.2024.01.001
Oliveira, D.L. et al., n.d. Biogenesis of fungal extracellular vesicles involves distinct secretory routes and complex cargo regulation. [No DOI available]
Oliveira, D.L., Nakayasu, E.S., Joffe, L.S., et al., 2020. Characterisation of Cryptococcus neoformans EVs: A role in brain invasion. mBio, 11(2), e03070–19. https://doi.org/10.1128/mBio.03070-19
Owolabi, A.O. et al. (2018) ‘Fungal infections in neonatal intensive care units in sub-Saharan Africa’, Current Fungal Infection Reports, 12(3), pp. 144–151. Available at: https://dx.doi.org/10.1007/s12281-018-0316-y
Pereira, G.H., Müller, M.E., Szeszs, M.W., et al., 2015. Biofilm formation by Candida species isolated from bloodstream infection. Revista do Instituto de Medicina Tropical de São Paulo, 57(4), pp.339–345. https://doi.org/10.1590/S0036-46652015000400014
Peres da Silva, R. et al. (2015) ‘Extracellular vesicle-mediated export of fungal RNA’, Scientific Reports, 5, 7763. https://doi.org/10.1038/srep07763
Pérez-Capó, M. et al. (2024). Therapeutic RNA delivery using engineered vesicles. DOI: https://doi.org/10.1016/j.molcel.2024.05.015
Pietrella, D. et al. (2010). Candida Secreted Aspartic Proteases Activate Inflammasomes. Infection and Immunity, 78(11), pp. 4761–4772. https://doi.org/10.1128/IAI.00532-10
Pietrella, D. et al. (2013). Inflammasome Pathway Induction by C. albicans EVs. Journal of Leukocyte Biology, 94(2), pp. 343–351. https://doi.org/10.1189/jlb.0113015
Pikman, Y. and Ben-Ami, R. (2012) ‘Use of molecular tools to predict safety in fungal immunotherapy’, Current Opinion in Infectious Diseases, 25(6), pp.586–591. https://doi.org/10.1097/QCO.0b013e328359a315
Pinzan, C.F., Martins, F.S. and Silva, R.A., 2024. Immune modulation by Aspergillus glycoproteins in host–pathogen interaction. Frontiers in Microbiology, 15, p.1171109. https://doi.org/10.3389/fmicb.2024.1171109
Ponde, N.O., Laversuch, C. and Ballou, E.R., 2021. Candida biofilms: Structure, function and impact on health. Pathogens, 10(8), p.925. https://doi.org/10.3390/pathogens10080925
Rajendran, R. et al. (2016). Clinical potential of EVs in fungal infection management. DOI: https://doi.org/10.1093/femsyr/fow078
Reis, F.C.G. et al. (2021) ‘A guide to fungal extracellular vesicles: cargo, mechanisms of release, and biotechnological applications’, Frontiers in Cellular and Infection Microbiology, 11, 689150. https://doi.org/10.3389/fcimb.2021.689150
Rezende, C.P. et al. (2024). Fungal Vesicles in Host–Pathogen Interaction. Frontiers in Cellular and Infection Microbiology, 14, 1170834. https://doi.org/10.3389/fcimb.2024.1170834
Ribeiro, M.C., Oliveira, M.B., Cardoso, B. et al., 2024. Neonatal candidiasis: Diagnosis, resistance, and clinical challenges. Journal of Fungi, 10(2), p.201. https://doi.org/10.3390/jof10020201
Rivera, J., Feldmesser, M., and Casadevall, A. (2023) ‘The influence of Cryptococcus neoformans EVs on host immune evasion and fungal persistence’, Journal of Immunology, 211(4), pp.870–880. https://doi.org/10.4049/jimmunol.2300120
Rizzo, J. et al. (2020) ‘Role of fungal EVs in biofilm formation and antifungal resistance’, Cellular Microbiology, 22(4), e13120. https://doi.org/10.1111/cmi.13120
Rizzo, J. et al. (2021) ‘Distinct extracellular vesicle–mediated export pathways in Cryptococcus neoformans’, mBio, 12(6), e03272-21. Available at: https://dx.doi.org/10.1128/MBIO.03272-21
Rizzo, J. et al. (2021) ‘Extracellular vesicles as an interface for host-pathogen interaction: lessons from fungal models’, Current Opinion in Microbiology, 63, pp. 100–106. https://doi.org/10.1016/j.mib.2021.05.005
Rizzo, J. et al. (2021) ‘Immunoevasive properties of Cryptococcus neoformans EVs’, Microorganisms, 9(3), 573. https://doi.org/10.3390/microorganisms9030573
Rizzo, J. et al. (2021). Fungal EVs as Immunotherapeutic Adjuvants. Journal of Extracellular Vesicles, 10(8), e12189. https://doi.org/10.1002/jev2.12189
Rizzo, J. et al., 2020. The fungal extracellular vesicle: is it a common delivery system for bioactive molecules in fungal-host interactions?. Frontiers in Cellular and Infection Microbiology, 10, p.591572. https://doi.org/10.3389/fcimb.2020.591572
Rizzo, J. et al., 2021. New insights into fungal extracellular vesicles: composition, biological functions, and impact on human health. Cellular Microbiology, 23(3), e13211. https://doi.org/10.1111/cmi.13211
Rizzo, J., Rodrigues, M.L. and Janbon, G., 2021. Extracellular vesicles in Cryptococcus spp.: architecture, functions, and virulence. Molecular Microbiology, 115(3), pp.387–394. https://doi.org/10.1111/mmi.14616
Rodrigues, M.L. et al. (2016) ‘Vesicular mechanisms of fungal communication’, mSphere, 1(1), e00099-15. Available at: https://dx.doi.org/10.1128/msphere.00099-16
Rodrigues, M.L. et al. (2019) ‘Fungal extracellular vesicles: Modulating host–pathogen interactions’, Nature Reviews Microbiology, 17(6), pp. 347–359. https://doi.org/10.1038/s41579-019-0193-2
Rodrigues, M.L., et al., 2011. Extracellular vesicles produced by Cryptococcus neoformans contain protein components associated with virulence. Eukaryotic Cell, 10(5), pp. 611–618. https://doi.org/10.1128/EC.00239-10
Román, E. et al. (2019). CRISPR/Cas9 tools for functional genomics in Candida albicans. DOI: https://doi.org/10.1016/j.fgb.2019.05.002
Saha, S. et al. (2022). Immune Vulnerability in Neonates and Fungal Pathogenesis. Paediatric Infectious Disease Journal, 41(5), pp. 312–318. https://doi.org/10.1097/INF.0000000000003521
Sampah, M.E. and Hackam, D.J. (2020) ‘Neonatal immune development and susceptibility to fungal pathogens’, Seminars in Perinatology, 44(3), 151214. https://doi.org/10.1053/j.semperi.2020.151214
Sangild, P.T., Siggers, R.H., Schmidt, M. et al. (2021) ‘Immunological development in preterm neonates: implications for fungal infection susceptibility’, Frontiers in Pediatrics, 9, 679813. https://doi.org/10.3389/fped.2021.679813
Satish, S. et al. (2020). Engineering filamentous fungi with CRISPR. DOI: https://doi.org/10.1016/j.copbio.2020.02.005
Schorey, J.S. and Harding, C.V., 2016. Extracellular vesicles and infectious disease: Emerging targets for therapeutic intervention. Clinical Microbiology Reviews, 29(1), pp.155–171. https://doi.org/10.1128/CMR.00081-14
Shevach, E.M., 1985. Mechanism of action of cyclosporin A. Immunopharmacology, 10(2), pp.97–106. https://doi.org/10.1016/0162-3109(85)90011-5
Shopova, I.A. et al. (2020) ‘Neutrophil-derived extracellular vesicles promote fungal killing through reactive oxygen species’, Frontiers in Immunology, 11, 62. https://doi.org/10.3389/fimmu.2020.00062
Silva, B.M., et al., 2019. Extracellular vesicles from Paracoccidioides brasiliensis induced M1 polarization in macrophages in a TLR2 dependent manner. Frontiers in Microbiology, 10, p.713. https://doi.org/10.3389/fmicb.2019.00713
Silva, L.V. et al. (2019) ‘Fungal extracellular vesicles and neuroinvasion in neonatal cryptococcosis’, mSphere, 4(6), e00511–19. https://doi.org/10.1128/mSphere.00511-19
Silva, V.K.A. et al. (2020) ‘Extracellular vesicles: an overview of biogenesis, composition, functions, and potential therapeutic applications in fungi’, Journal of Fungi, 6(2), 65. https://doi.org/10.3390/jof6020065
Simpson, A. et al. (2021) ‘Neonatal fungal sepsis: An emerging threat and a call for attention’, Children, 8(7), p. 572. Available at: https://dx.doi.org/10.3390/children8070572
Singh, A. et al., 2022. Passive immunisation in neonatal candidiasis. Infectious Immunology, 90(6), e00654-21. https://doi.org/10.1128/IAI.00654-21
Singh, S., Nabeela, S., Barbarino, A., Ibrahim, A.S. and Uppuluri, P. (2022) ‘Antibodies targeting Candida albicans Als3 and Hyr1 antigens protect neonatal mice from candidiasis’, Frontiers in Immunology, 13, 925821. https://doi.org/10.3389/fimmu.2022.925821
Smith, R. et al. (2020) ‘Cargo profiling of Candida and Cryptococcus extracellular vesicles reveals biofilm-related functions’, Cellular Microbiology, 22(8), e13293. https://doi.org/10.1111/cmi.13293
Souza, J.A.M. et al. (2019) ‘Protective effect of Aspergillus fumigatus extracellular vesicles in a murine model of invasive aspergillosis’, Scientific Reports, 9, 947. https://doi.org/10.1038/s41598-018-37410-1
Souza, J.A.M., Costa, M.C.S., and Almeida, F. (2022) ‘Extracellular vesicles from Aspergillus fumigatus modulate the immune system and improve fungal clearance in vivo’, Microbial Pathogenesis, 164, 105414. https://doi.org/10.1016/j.micpath.2021.105414
Souza, J.A.M., Piffer, A.C., Fraga-Silva, T.F.C. et al., 2019. Aspergillus extracellular vesicles induce cytokine production. Scientific Reports, 9(1), p.14744. https://doi.org/10.1038/s41598-019-51133-6
Specht, C.A. et al. (2017) ‘Protection against experimental cryptococcosis following vaccination with glucan particles containing Cryptococcus alkaline extract’, mBio, 8(6), e01838-17. https://doi.org/10.1128/mBio.01838-17
Stoll, B.J. et al. (2012) ‘Neonatal candidiasis in extremely low birth weight infants: Risk factors and outcomes’, Early Human Development, 88, pp. S6–S9. Available at: https://dx.doi.org/10.1016/S0378-3782(12)70004-X
Stranford, D.M. et al. (2022). T cell-targeted EVs for immunotherapy. DOI: https://doi.org/10.1016/j.immuni.2022.07.009
Subedi, K. P. et al., 2021. Characterisation of EVs from Saccharomyces cerevisiae. Journal of Fungi, 7(4), p.275. https://doi.org/10.3390/jof7040275
Szymański, H. et al. (2015) ‘Invasive fungal infections in neonates: Epidemiology, prevention and treatment’, Journal of Maternal-Fetal and Neonatal Medicine, 28(18), pp. 2114–2120. Available at: https://dx.doi.org/10.3109/14767058.2014.954787
Tanaka, M. et al. (2020) ‘Role of extracellular vesicles in virulence and host interaction in fungal pathogens’, Medical Mycology, 58(3), pp. 396–407. https://doi.org/10.1093/mmy/myz104
Thompson, G.R. et al. (2022) ‘Extracellular vesicles in invasive fungal disease: diagnostic potential and biological roles’, Clinical Microbiology Reviews, 35(2), e00107-21. https://doi.org/10.1128/cmr.00107-21
Troha, K. et al. (2014) ‘Lactoferrin in health and disease: Current knowledge and future trends’, The Journal of Nutritional Biochemistry, 25(11), pp. 1101–1109. Available at: https://dx.doi.org/10.1016/j.jnutbio.2013.10.012
Ullah, A. et al. (2023) ‘Extracellular vesicles from fungi: Characterisation and potential for therapeutic applications’, Journal of Nanobiotechnology, 21, 70. https://doi.org/10.1186/s12951-023-01762-1
Ullah, A. et al. (2023). Immunological Profile of Cryptococcal Vesicles. International Journal of Medical Microbiology, 313(4), 151596. https://doi.org/10.1016/j.ijmm.2023.151596
Ullah, A. et al., 2023. Extracellular vesicles from fungi: Current knowledge and future perspectives. Microorganisms, 11(1), p.56. https://doi.org/10.3390/microorganisms11010056
Ullah, A., et al., 2023. Fungal extracellular vesicles: new insights into pathogenicity and therapeutic targets. Journal of Fungi, 9(2), p.164. https://doi.org/10.3390/jof9020164
Ullah, A., Huang, Y., Zhao, K. and Zheng, L., 2023. Characteristics and potential clinical applications of the extracellular vesicles of human pathogenic Fungi. BMC Microbiology. Figure reprinted with permission http://dx.doi.org/10.1186/s12866-023-02945-3
Vargas, G. et al. (2015) ‘Protective effect of fungal extracellular vesicles against murine candidiasis’, Cellular Microbiology, 17(3), pp. 479–494. https://doi.org/10.1111/cmi.12374
Vargas, G. et al. (2015). EVs in Candida–Host Interactions. mBio, 6(2), e00312-15. https://doi.org/10.1128/mBio.00312-15
Vargas, G. et al. (2018) ‘Compositional and immunobiological analyses of extracellular vesicles released by Candida albicans’, Frontiers in Microbiology, 9, 2676. Available at: https://dx.doi.org/10.3389/fmicb.2018.02676
Vargas, G. et al. (2020). EVs and Fungal Virulence in Neonates. Pathogens, 9(7), 510. https://doi.org/10.3390/pathogens9070510
Vargas, G. et al. (2020). Immunostimulatory potential of Candida EVs. DOI: https://doi.org/10.1016/j.vaccine.2020.02.006
Vargas, G. et al., 2020. Immunostimulatory effects of EVs from Candida albicans. mSphere, 5(3), e00522-20. https://doi.org/10.1128/mSphere.00522-20
Vargas, G., Rocha, J.D., Oliveira, D.L., Albuquerque, P.C., Frases, S., Santos, S.S., Nosanchuk, J.D., Gomes, A.M., Medeiros, L.C., Miranda, K. and Casadevall, A., 2020. Compositional and immunobiological analyses of extracellular vesicles released by Candida albicans. Cellular Microbiology, 17(3), pp.389–407. https://doi.org/10.1111/cmi.12374
Vargas, G., Rocha, J.D.B., Oliveira, D.L., Albuquerque, P.C., Frases, S., Santos, S.S., Nosanchuk, J.D., Gomes, A.M.O., Medeiros, L.C.A., Miranda, K. and Casadevall, A., 2020. Compositional and immunobiological analyses of extracellular vesicles released by Candida albicans. Cellular Microbiology, 17(3), pp.389–407. https://doi.org/10.1111/cmi.12374
Veziroglu, E. M. & Mias, G. I., 2020. Application of EV databases in precision medicine. Frontiers in Genetics, 11, p.14. https://doi.org/10.3389/fgene.2020.00014
Vu, K., Weksler, B., Romero, I., et al., 2013. Cryptococcus neoformans EVs modulate BBB permeability and inflammation. PLoS Pathogens, 9(6), e1003477. https://doi.org/10.1371/journal.ppat.1003477
Wang, X. et al. (2023) ‘Vaccination with inactivated extracellular vesicles protects immunocompromised mice against Cryptococcus infection’, Frontiers in Immunology, 14, 1010253. https://doi.org/10.3389/fimmu.2023.1010253
Wang, Y. et al. (2021) ‘Extracellular vesicles from Cryptococcus neoformans modulate host immunity and promote virulence in a murine model’, PLOS Pathogens, 17(6), e1009511. https://doi.org/10.1371/journal.ppat.1009511
Wartburg, J.P. and Traber, R., 1988. Mechanisms of action of cyclosporin A: A pharmacological overview. Transplantation Proceedings, 20(3 Suppl 3), pp.115–120. https://doi.org/10.1016/0041-1345(88)90030-3
Wazir, S. & Kumar, P. (2006) ‘Neonatal fungal infections: Newer challenges’, Medical Journal Armed Forces India, 62(2), pp. 135–139. https://doi.org/10.1016/S0377-1237(06)80038-5
Wazir, S. & Kumar, R., 2006. Neonatal fungal infections: Risk and treatment. Indian Journal of Paediatrics, 73(12), pp.1135–1142. https://doi.org/10.1007/BF02859360
Weimer, K.E.D. et al. (n.d.) ‘Fungal infections in premature infants: Prevention and management’, Expert Review of Anti-infective Therapy, In press. [DOI not available]
Wilson, C.B. and Lewis, D.B. (1990) ‘Immunological basis of neonatal susceptibility to infections’, Pediatric Research, 27(1), pp.14–19. https://doi.org/10.1203/00006450-199001000-00004
Wu, C.-F., et al., 2023. Fungal extracellular vesicles: emerging roles in immunopathology and antifungal strategies. Mycopathologia, 188(2), pp. 213–229. https://doi.org/10.1007/s11046-023-00668-2
Wu, D. et al., 2019. EVs in cancer metastasis and drug resistance. Nature Reviews Cancer, 19(12), pp.759–771. https://doi.org/10.1038/s41568-019-0194-1
Wu, X., Zhang, L., Xu, H., et al., 2023. EVs as biomarkers and therapeutic agents in neonatal diseases. Theranostics, 13(4), pp.1485–1503. https://doi.org/10.7150/thno.80052
Wynn, J.L. and Levy, O. (2010) ‘Role of innate host defenses in susceptibility to early-onset neonatal sepsis’, Clinics in Perinatology, 37(2), pp. 307–337. https://doi.org/10.1016/j.clp.2010.04.002
Yáñez-Mó, M. et al. (2015) ‘Biological properties of extracellular vesicles and their physiological functions’, Journal of Extracellular Vesicles, 4, 27066. https://doi.org/10.3402/jev.v4.27066
Yang, R., Sun, P., Fan, T., et al., 2018. Biosynthesis of cyclosporin A in Tolypocladium inflatum. Fungal Biology Reviews, 32(2), pp.59–68. https://doi.org/10.1016/j.fbr.2018.01.001
Yu, Z., Kang, H., & Liu, Y. (2023) ‘Engineering fungal extracellular vesicles: Promising role in nanobiotechnology and therapeutics’, Extracellular Vesicles and Circulating Nucleic Acids, 4(2), pp. 75–90. Available at: https://dx.doi.org/10.20517/evcna.2023.04
Yuan, H. et al. (2024). Yeast-derived EVs as mRNA delivery systems. DOI: https://doi.org/10.1016/j.nano.2024.103423
Zamith-Miranda, D. et al. (2020) ‘Comparative molecular and immunoregulatory analysis of extracellular vesicles from Candida albicans and Candida auris’, mSphere, 5(2), e00484-19. Available at: https://dx.doi.org/10.1128/msphere.00484-19
Zamith-Miranda, D. et al. (2020) ‘Proteomic analysis of Candida albicans extracellular vesicles reveals virulence-associated cargo’, Frontiers in Microbiology, 11, 1837. https://doi.org/10.3389/fmicb.2020.01837
Zamith-Miranda, D., Nimrichter, L., Rodrigues, M.L. and Nosanchuk, J.D., 2021. Fungal extracellular vesicles: modulating host–pathogen interactions by both the fungi and the host. Microbiology Spectrum, 9(1), e00468-21. https://doi.org/10.1128/Spectrum.00468-21
Zamith-Miranda, D., Nimrichter, L., Rodrigues, M.L., and Nosanchuk, J.D. (2020) ‘Fungal extracellular vesicles: modulating host-pathogen interactions’, mSphere, 5(4), e00511-20. https://doi.org/10.1128/mSphere.00511-20
Zarnowski, R. et al. (2018). Vesicle-mediated communication in fungal infections. DOI: https://doi.org/10.1128/IAI.00535-18
Zarnowski, R., Sanchez, H., Covelli, A.S., Dominguez, E., Jaromin, A., Berhardt, J., Mitchell, K.F., Heiss, C., Azadi, P., Mitchell, A.P. and Andes, D.R., 2018. Candida albicans biofilm-induced vesicles confer drug resistance through matrix biogenesis. PLoS Biology, 16(10), p.e2006872. https://doi.org/10.1371/journal.pbio.2006872
Zhang, Q., Wang, Z., Wu, C. et al., 2021. Cryptococcus EVs influence cytoskeletal proteins and BBB integrity. mSphere, 6(3), e00228–21. https://doi.org/10.1128/mSphere.00228-21
Zhang, Y. et al. (2024). Comparative study of lipid nanoparticles and EVs in mRNA vaccine delivery. DOI: https://doi.org/10.1016/j.addr.2024.114949
